Aprezo 30mg
| SKU | 2134 |
|---|---|
| Generic For | Otezla |
| Strength | 30mg |
| Manufacturer | Glenmark |
| Active Ingredient | Apremilast |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.67 | US$ 20.00 | |||
|
|||||
| 60 Tablet/s | US$ 0.58 | US$ 35.0012%US$ 40.00 | |||
|
|||||
| 90 Tablet/s | US$ 0.56 | US$ 50.0017%US$ 60.00 | |||
|
|||||
Aprezo 30mg (Apremilast) – Affordable Otezla Alternative
Aprezo 30 mg contains the active ingredient Apremilast, which belongs to a class of medications known as phosphodiesterase 4 inhibitors, which help to reduce inflammation. It is effective in treating adults with the following conditions:
- Active psoriatic arthritis (an inflammatory disease of the joints, usually accompanied by psoriasis, an inflammatory disorder of the skin)- If you can't use another type of medicine called disease-modifying antirheumatic drugs or when you already tried one of these drugs and it did not work.
- Moderate to severe chronic plaque psoriasis (an inflammatory disease of the skin which causes red, thick, itchy, scaly, and painful patches on the skin)- If you can't use one of the following treatments or when you have already tried one of these treatments, and it did not work:
- Phototherapy is a treatment where certain skin areas are exposed to ultraviolet light
- Systematic therapy affects the entire body rather than just one local area, such as cyclosporin and methotrexate.
- Behcet's disease (a rare type of inflammatory disorder affecting many body parts)- For the treatment of mouth ulcers, a common problem for people with this illness.
All three diseases are lifelong conditions, and there is currently a cure. Apremilast, the active ingredient in the medicine, works by reducing the action of the phosphodiesterase 4 enzyme, which is involved in the inflammation process. By reducing the activity of this enzyme. Apremilast helps to control the inflammation associated with psoriasis, psoriatic arthritis, and Behcet's disease, thereby reducing the signs of these conditions. The medicine has been shown to improve the quality of life in patients with the conditions mentioned above.
Do not take Aprezo if allergic to Apremilast or any of the medicine's ingredients. The use of Aprezo is also prohibited if you are pregnant or think you may be pregnant. Speak to your doctor before taking this medicine. Inform your doctor before initiating treatment with Aprezo if you have depression which is getting worse with thoughts of suicide.
Let your doctor know if you are dealing with severe kidney problems. The medicine has not been studied in children and adolescents; therefore, it is not recommended for use in children and adolescents aged 17 years and under. Also, inform your doctor if you are taking any other medicine. These include antibiotics for tuberculosis, antiseizure drugs, and St John's wort (herbal medicine for anxiety and depression).
Common side effects of Aprezo 30mg are nausea, diarrhoea, cough, loss of appetite, tiredness, back pain, vomiting, migraine, depression, difficulty sleeping, frequent bowel movements, common cold, and tension headaches. If you get any side effects, talk to your doctor. This includes any possible side effects not listed here.
Patients are instructed to take Aprezo only as prescribed by the doctor. The recommended dose is 30 mg twice daily, one 30 mg dose in the morning, and one 30 mg dose in the evening, approximately twelve hours apart, before or after consuming food. If you have severe kidney disease, then the recommended dose is 30 mg once daily. If your condition hasn't improved after six months of treatment, you should speak to your doctor.
What is Apremilast and what condition does it treat?
Apremilast, marketed as Aprezo 30mg, is an oral phosphodiesterase-4 (PDE4) inhibitor used to treat moderate to severe plaque psoriasis and active psoriatic arthritis in adults. This immunomodulator works differently from traditional biologics, offering an oral treatment option for inflammatory skin conditions and joint inflammation. Aprezo 30mg helps reduce the plaques, scaling, and redness associated with psoriasis while also managing painful joint symptoms in psoriatic arthritis patients. As a systemic therapy, apremilast addresses the underlying inflammatory processes rather than just surface symptoms, making it suitable for patients requiring more than topical treatments alone.
How does Apremilast work in the body?
Apremilast functions by inhibiting phosphodiesterase-4 (PDE4), an enzyme found inside immune cells that controls inflammatory responses. By blocking PDE4, Aprezo 30mg increases levels of cyclic adenosine monophosphate (cAMP) within cells, which helps regulate the production of inflammatory cytokines. This PDE4 inhibitor reduces pro-inflammatory mediators like TNF-alpha and interleukins while increasing anti-inflammatory substances. The result is decreased inflammation in both skin tissue and joints. Unlike biologic injections that target specific proteins, apremilast works intracellularly to modulate multiple inflammatory pathways simultaneously, offering broad anti-inflammatory effects through a convenient oral tablet format.
How long does Aprezo 30mg take to work?
Most patients notice initial improvements in psoriasis symptoms within two to four weeks of starting Aprezo 30mg, though full therapeutic benefits typically develop over 16 to 24 weeks of continuous treatment. For psoriatic arthritis, joint pain and swelling reduction may begin within the first month, with optimal results emerging after three to six months. The apremilast response timeline varies individually based on disease severity and personal physiology. Some patients experience earlier relief, while others require longer treatment periods to achieve maximum benefit. Consistent daily dosing is essential for effectiveness, as this oral PDE4 inhibitor maintains steady anti-inflammatory activity.
When and how should I take Aprezo 30mg?
Aprezo 30mg should be taken twice daily, approximately 12 hours apart, with or without food. Treatment begins with a titration schedule over five days, starting at lower doses and gradually increasing to the maintenance dose of 30mg twice daily. Swallow tablets whole without crushing or splitting them. Taking apremilast at consistent times each day helps maintain stable medication levels. If you miss a dose, take it as soon as remembered unless it's nearly time for the next scheduled dose—never double up. Your healthcare provider will provide specific titration instructions to minimize gastrointestinal side effects during the initial adjustment period.
Is Aprezo 30mg safe for long-term use?
Clinical studies demonstrate that Aprezo 30mg can be used safely for extended periods when treating chronic conditions like psoriasis and psoriatic arthritis. Long-term data spanning several years shows consistent safety profiles with continued apremilast therapy. Unlike some systemic treatments, this oral PDE4 inhibitor doesn't require routine blood monitoring or increase serious infection risks to the same degree as certain immunosuppressants. Most adverse effects are mild to moderate and often diminish after the first few weeks. Patients should attend regular follow-up appointments so healthcare providers can monitor treatment response and overall health status throughout ongoing therapy.
Can I take Aprezo 30mg with other medicines?
Aprezo 30mg has relatively few drug interactions compared to many systemic psoriasis treatments, making it compatible with numerous medications. However, strong enzyme inducers like rifampin, phenytoin, carbamazepine, and St. John's Wort can reduce apremilast effectiveness by increasing its metabolism. This oral immunomodulator can generally be combined with topical psoriasis treatments, non-biologic arthritis medications, and most common prescriptions. Always disclose your complete medication list, including over-the-counter products and supplements, to your healthcare provider. They'll assess potential interactions and adjust your treatment plan accordingly. The favourable interaction profile makes Aprezo suitable for patients with multiple health conditions requiring various medications.
How does Aprezo 30mg compare to similar medicines in its class?
Aprezo 30mg stands out among psoriasis and psoriatic arthritis treatments as an oral PDE4 inhibitor, offering advantages over injectable biologics. Unlike TNF inhibitors or IL-17 blockers that require injections, apremilast provides convenient tablet administration without needles. It doesn't suppress the immune system as broadly as methotrexate or cyclosporine, potentially reducing infection risks. Compared to biologics, this oral immunomodulator requires no refrigeration and involves no injection-site reactions. While biologic medications may produce more dramatic results in severe cases, Aprezo offers a favourable safety profile with moderate efficacy, making it ideal for patients preferring oral therapy or unsuitable for biologic treatments.
Is the generic Apremilast as effective as branded versions?
Generic apremilast contains the identical active pharmaceutical ingredient as branded versions like Aprezo 30mg and must meet strict bioequivalence standards set by regulatory authorities. These requirements ensure generic formulations deliver the same therapeutic effects, safety profile, and dosing as brand-name products. The active ingredient works identically whether in generic or branded form—both inhibit PDE4 to reduce inflammation in psoriasis and psoriatic arthritis. Generic medications undergo rigorous testing to confirm they perform equivalently to original branded products. Choosing between generic apremilast and branded Aprezo typically comes down to cost considerations and availability, as therapeutic outcomes remain consistent across approved formulations.
Why do patients choose PremiumRxDrugs for Aprezo 30mg?
Patients select PremiumRxDrugs for Aprezo 30mg because of competitive pricing on both branded and generic apremilast formulations, making long-term psoriasis and psoriatic arthritis treatment more affordable. The pharmacy guarantees authentic, manufacturer-sourced medications, eliminating concerns about counterfeit products. With more than ten years serving international customers across the USA, UK, Australia, and Canada, PremiumRxDrugs has built trust through consistent service quality. Discreet packaging protects privacy, while convenient prescription management simplifies ongoing treatment. Free shipping options reduce overall medication costs. The combination of affordability, authenticity guarantees, established reputation, and patient-friendly services makes PremiumRxDrugs a preferred source for purchasing this oral PDE4 inhibitor.
What are the common side effects of Apremilast?
Common side effects of apremilast include diarrhea, nausea, upper respiratory infections, headache, and tension-type headaches, particularly during the initial weeks of treatment. Many patients experience gastrointestinal symptoms like abdominal pain or decreased appetite when starting this PDE4 inhibitor, though these typically improve as the body adjusts. Weight loss occurs in some individuals taking apremilast. Less common but notable effects include mood changes, including depression or anxiety in susceptible patients. Most adverse reactions are mild to moderate in severity and often resolve within the first month. The titration schedule used when initiating treatment helps minimize gastrointestinal discomfort during the adjustment period.
Who should avoid taking Apremilast?
Apremilast should be avoided by individuals with known hypersensitivity to the active ingredient or any tablet components. Patients with severe renal impairment require dose adjustments, as kidney function affects medication clearance. Those with a history of depression, suicidal thoughts, or suicidal behaviour need careful evaluation before starting this PDE4 inhibitor, as apremilast may increase depression risk in susceptible individuals. Pregnant women should use caution, as safety during pregnancy hasn't been fully established. Breastfeeding mothers should discuss potential risks with healthcare providers. Patients experiencing unexplained weight loss or severe gastrointestinal symptoms may need treatment reassessment. Individual medical history determines suitability for this oral immunomodulator therapy.
Login
Sign Up
Login
Sign Up